10x Genomics: Deciphering The Preliminary Q3 Earnings

Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial. In my last 10x Genomics (NASDAQ: TXG ) article , I discussed how the ticker had been under relentless selling pressure, dropping from $209 in June 2021 to around $20 at the time of publication. 10x had been able to report some modest growth in He is the ...